N-bromobutanimide → HCID 86649133, compound
Reaction equation
[CH3:1][O:2][C:3](=[O:62])[NH:4][C@@H:5]([CH:59]([CH3:61])[CH3:60])[C:6](=[O:58])[N:7]1[CH2:11][CH2:10][CH2:9][C@@:8]1([C:55](=[O:57])[NH2:56])[C:12]1[CH:17]=[CH:16][C:15]([C:18]2[N:22]([C:23]3[CH:28]=[CH:27][C:26]([F:29])=[CH:25][CH:24]=3)[C:21]([C:30]3[CH:35]=[CH:34][C:33]([C@:36]4([C:52](=[O:54])[NH2:53])[CH2:40][CH2:39][CH2:38][N:37]4[C:41](=[O:51])[C@@H:42]([NH:46][C:47](=[O:50])[O:48][CH3:49])[CH:43]([CH3:45])[CH3:44])=[CH:32][CH:31]=3)=[CH:20][CH:19]=2)=[CH:14][CH:13]=1.[Br:63]N1C(=O)CCC1=O>C(Cl)Cl>[CH3:1][O:2][C:3](=[O:62])[NH:4][C@@H:5]([CH:59]([CH3:61])[CH3:60])[C:6](=[O:58])[N:7]1[CH2:11][CH2:10][CH2:9][C@@:8]1([C:55](=[O:57])[NH2:56])[C:12]1[CH:17]=[CH:16][C:15]([C:18]2[N:22]([C:23]3[CH:24]=[CH:25][C:26]([F:29])=[CH:27][CH:28]=3)[C:21]([C:30]3[CH:35]=[CH:34][C:33]([C@:36]4([C:52](=[O:54])[NH2:53])[CH2:40][CH2:39][CH2:38][N:37]4[C:41](=[O:51])[C@@H:42]([NH:46][C:47](=[O:50])[O:48][CH3:49])[CH:43]([CH3:45])[CH3:44])=[CH:32][CH:31]=3)=[C:20]([Br:63])[CH:19]=2)=[CH:14][CH:13]=1Participants
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
To a suspension of the product from Example 51 (455 mg, 0.534 mmol) in CH2Cl2 (2.7 mL) was added a mixture of 1-bromopyrrolidine-2,5-dione (95 mg, 0.534 mmol) in CH2Cl2 (2.7 mL). The mixture was stirred overnight at room temperature then concentrated under reduced pressure and triturated with diethyl ether to provide a mixture of compounds that was subjected to reverse phase HPLC purification eluted with a gradient of 60-100% MeOH in 10 mM ammonium acetate to afford the title compound (84 mg, 17% yield). 1H NMR (free base) (400 MHz, DMSO-D6) δ 10.06 (s, 1H), 10.02 (s, 1H), 7.46 (d, J=8.7, 2H), 7.41 (d, J=8.7, 2H), 7.30 (d, J=7.7, 2H), 7.15-7.03 (m, 6H), 6.98 (d, J=8.7, 2H), 6.53 (s, 1H), 4.45-4.33 (m, 2H), 4.01 (t, J=7.7, 2H), 3.85-3.73 (m, 2H), 3.66-3.54 (m, 2H), 3.51 (s, 6H), 2.20-2.05 (m, 2H), 2.03-1.77 (m, 8 H), 0.97-0.79 (m, 12H). MS (ESI; M+H) m/z=933.
Workup
- additionwas added
- concentrationthen concentrated under reduced pressure
- customtriturated with diethyl ether
- customto provide
- additiona mixture of compounds that
- customphase HPLC purification
- washeluted with a gradient of 60-100% MeOH in 10 mM ammonium acetate
Sources & evidence
- ORD record
- ord-7594896f3daa466ba4510936750e5755
- Source dataset
- uspto-grants-2014_04
- Patent number
- US08691938B2
Reaction notes
Loading…